slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,471
Current window 23,851-23,880
Pages 3,683
Rows per page 30
Component
23,851-23,880 of 110,471
32
Immatics | Investor Presentation Deck | 75 slidesImmatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · Traction3 hits
35
The slide uses a chevron-based process flow to represent a phased development roadmap.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Loop · Quick Win Big Bet3 hits
46
Includes a schematic diagram of the bispecific molecule on the left.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 3 hits
54
The slide uses a process flow diagram to illustrate the transition from dose escalation to expansion cohorts.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 3 hits
58
The slide outlines a standard clinical trial progression from overview to dose escalation and expansion.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 3 hits
45
Slide presents three distinct preclinical data sets: survival in STS mice, tumor response in STS mice, and survival in KPC pancreatic cancer mice.Immix Biopharma | Investor Presentation Deck | 60 slides · Immix Biopharma
Pitch deck Investor relations Loop · Golden Circle3 hits
56
The slide uses a side-by-side comparison of two proprietary technology platforms.Immix Biopharma | Investor Presentation Deck | 60 slides · Immix Biopharma
Pitch deck Investor relations Loop · Golden Circle3 hits
40
Slide presents three distinct preclinical data sets: survival in STS, tumor response in STS, and survival in KPC pancreatic cancer models.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action3 hits
41
Includes a process flow diagram illustrating the mechanism of action of iMX-110 in tumor microenvironments.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action3 hits
56
Immix Biopharma | Investor Presentation Deck | 61 slidesImmix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action3 hits
41
Slide contains three distinct charts comparing IMX-110 against standard of care in mouse models.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations 3 hits
42
Includes a process flow diagram illustrating the mechanism of action of IMX-110 in tumor microenvironments.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations 3 hits
52
Includes a comparative size diagram of the drug vs IgG antibody and a Kaplan-Meier survival curve.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations 3 hits
57
The slide uses a side-by-side comparison structure to explain two distinct proprietary platforms.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations 3 hits
05
The slide uses a split layout with a dark sidebar for branding and a large photo of the vehicle on the right.Innoviz | Results Presentation Deck | 20 slides · Innoviz Technologies
Conference presentation Investor relations Beat · Key Takeaways3 hits
13
The slide uses a three-column layout to summarize market dynamics.Innoviz | Results Presentation Deck | 20 slides · Innoviz Technologies
Conference presentation Investor relations Loop · Cost Of Inaction3 hits
05
Invitae | Results Presentation Deck | 27 slidesInvitae | Results Presentation Deck | 27 slides · Invitae
Conference presentation Investor relations Beat · NeedLoop · Why Now3 hits
13
Kering | Fixed Income Presentation Deck | 35 slidesKering | Fixed Income Presentation Deck | 35 slides · Kering
Deck Investor relations Beat · Solution3 hits
16
The chart is a waterfall bridge showing the transition from Q3 22 to Q3 23 revenue.Kering | Fixed Income Presentation Deck | 35 slides · Kering
Deck Investor relations Beat · FinancialsLoop · Zoom In3 hits
19
Kering | Fixed Income Presentation Deck | 35 slidesKering | Fixed Income Presentation Deck | 35 slides · Kering
Deck Investor relations Beat · Financials3 hits
27
The slide uses a horizontal timeline structure to present sequential or milestone-based strategic goals.Kering | Fixed Income Presentation Deck | 35 slides · Kering
Deck Investor relations 3 hits
11
The slide uses a three-column layout to categorize strategic initiatives, each supported by a descriptive image.Kering | Investor Presentation Deck | 63 slides · Kering
Conference presentation Investor relations Beat · Solution & ApproachLoop · Golden Circle3 hits
14
Waterfall chart shows the bridge from Q3 22 to Q3 23 revenue.Kering | Investor Presentation Deck | 63 slides · Kering
Conference presentation Investor relations Beat · Solution & ApproachLoop · Golden Circle3 hits
24
The slide highlights investment activities and financial health indicators.Kering | Investor Presentation Deck | 63 slides · Kering
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Cost Of Inaction3 hits
26
The slide uses a central donut chart to represent the 12 directors, with branches connecting to headshots and titles.Kering | Investor Presentation Deck | 63 slides · Kering
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Cost Of Inaction3 hits
33
The slide uses a side-by-side comparison structure to detail two distinct corporate sustainability funds.Kering | Investor Presentation Deck | 63 slides · Kering
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Cost Of Inaction3 hits
34
The diagram is a circular process model showing how different business stages contribute to circularity.Kering | Investor Presentation Deck | 63 slides · Kering
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Cost Of Inaction3 hits
36
The slide uses a hub-and-spoke style layout to categorize sustainability achievements.Kering | Investor Presentation Deck | 63 slides · Kering
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Cost Of Inaction3 hits
06
The slide uses a medical context to establish the severity of the condition and the unmet medical need.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction3 hits
18
Larimar Therapeutics | Investor Presentation Deck | 44 slidesLarimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet3 hits